Chromocell Therapeutics Statistics

Total Valuation

CHRO has a market cap or net worth of $7.32 million. The enterprise value is $3.55 million.

Market Cap	7.32M
Enterprise Value	3.55M

Important Dates

The next estimated earnings date is Tuesday, August 20, 2024, before market open.

Earnings Date	Aug 20, 2024
Ex-Dividend Date	n/a

Share Statistics

CHRO has 5.77 million shares outstanding. The number of shares has increased by 322.19% in one year.

Shares Outstanding	5.77M
Shares Change (YoY)	+322.19%
Shares Change (QoQ)	+267.48%
Owned by Insiders (%)	72.78%
Owned by Institutions (%)	5.42%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	6.48
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.39, with zero debt.

Current Ratio	1.39
Quick Ratio	1.31
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-7.20

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-848.30%
Return on Capital (ROIC)	-697.42%
Revenue Per Employee	n/a
Profits Per Employee	-$2.24M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	1.57
200-Day Moving Average	n/a
Relative Strength Index (RSI)	41.04
Average Volume (20 Days)	14,146

Short Selling Information

The latest short interest is 2,637, so 0.05% of the outstanding shares have been sold short.

Short Interest	2,637
Short Previous Month	111
Short % of Shares Out	0.05%
Short % of Float	n/a
Short Ratio (days to cover)	0.09

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-7.88M
Pretax Income	-8.98M
Net Income	-8.98M
EBITDA	-7.88M
EBIT	-7.88M
Earnings Per Share (EPS)	-$7.03

Full Income Statement

Balance Sheet

The company has $3.77 million in cash and no debt, giving a net cash position of $3.77 million or $0.65 per share.

Cash & Cash Equivalents	3.77M
Total Debt	n/a
Net Cash	3.77M
Net Cash Per Share	$0.65
Equity (Book Value)	1.13M
Book Value Per Share	0.20
Working Capital	1.13M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-2.80M
Capital Expenditures	n/a
Free Cash Flow	-2.80M
FCF Per Share	-$0.60

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CHRO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-322.19%
Shareholder Yield	-322.19%
Earnings Yield	-122.57%
FCF Yield	-38.23%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2